Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Operating Leases: 2019-2025

Historic Operating Leases for Verastem (VSTM) over the last 7 years, with Sep 2025 value amounting to $800,000.

  • Verastem's Operating Leases changed negligibly% to $800,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $800,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $535,000 for FY2024, which is N/A change from last year.
  • As of Q3 2025, Verastem's Operating Leases stood at $800,000, which was down 23.37% from $1.0 million recorded in Q2 2025.
  • Verastem's Operating Leases' 5-year high stood at $3.4 million during Q1 2021, with a 5-year trough of $535,000 in Q4 2024.
  • Moreover, its 3-year median value for Operating Leases was $1.2 million (2024), whereas its average is $1.3 million.
  • Its Operating Leases has fluctuated over the past 5 years, first plummeted by 52.94% in 2024, then climbed by 2.15% in 2025.
  • Quarterly analysis of 5 years shows Verastem's Operating Leases stood at $2.3 million in 2021, then crashed by 33.75% to $1.5 million in 2022, then plummeted by 30.41% to $1.7 million in 2023, then tumbled by 52.94% to $535,000 in 2024, then remained steady at $800,000 in 2025.
  • Its Operating Leases was $800,000 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.3 million in Q1 2025.